Wacker Chemie AG stock analysis
Wacker Chemie AG (0NR4) Share Price & Analysis
0NR4 Stock Chart & Stats
- Day’s Range
- EUR 80.40 - EUR 82.40
- 52-Week Range
- EUR 62.00 - EUR 106.00
- Previous Close
- EUR 81.00
- Volume
- N/A
- Average Volume (3M)
- 1,772
- Market Cap
- EUR 3.99B
- Enterprise Value
- EUR 5.40B
- Total Cash (Recent Filing)
- EUR 2.10B
- Total Debt (Recent Filing)
- EUR 2.31B
- Price to Earnings (P/E)
- ―
- Beta
- 1.54
- Next Earnings
- Mar 08, 2027 (Est.)
- EPS Estimate
- 0.74
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 3.09%
Bulls Say, Bears Say
Bulls Say
Structural Cost Savings
PACE is described as structural rather than temporary, giving Wacker a durable route to lower its cost base and improve competitiveness. If delivered, the savings can support margins across the cycle, offset inflation, and strengthen cash generation without relying solely on market recovery.
Balance Sheet And Liquidity
A sizeable equity base, substantial liquidity, and declining net debt provide financial resilience while chemical markets remain cyclical. This supports continued investment in existing assets, reduces refinancing pressure, and gives management flexibility to navigate weak demand.
Diversified Specialty Portfolio
Exposure to multiple industries, geographies, and product categories reduces reliance on any single customer market and supports resilience through differing economic cycles. Specialty chemicals and biosolutions also provide several avenues for customer retention and longer-term growth.
Bears Say
Persistent Weak Profitability
Continued net losses show that operating earnings are not currently translating into shareholder returns, despite positive EBITDA. Negative ROE and the sharp decline from prior profitable years indicate elevated earnings volatility and could constrain internally funded growth if weakness persists.
Solar Polysilicon Underutilization
Low utilization spreads fixed costs over fewer units and makes polysilicon profitability vulnerable while solar demand and pricing remain weak. The drag can persist beyond a single quarter because plant economics depend on industry capacity balance and recovery in the solar market.
Biosolutions Below Potential
Underfilled biotechnology and CDMO capacity limits near-term operating leverage and leaves invested assets generating below-potential returns. A gradual commercial ramp means this segment may require sustained execution before it becomes a meaningful and dependable contributor to group profitability.
Wacker Chemie AG News
0NR4 FAQ
What was Wacker Chemie AG’s price range in the past 12 months?
What is Wacker Chemie AG’s market cap?
When is Wacker Chemie AG’s upcoming earnings report date?
How were Wacker Chemie AG’s earnings last quarter?
Is Wacker Chemie AG overvalued?
Does Wacker Chemie AG pay dividends?
What is Wacker Chemie AG’s EPS estimate?
How many shares outstanding does Wacker Chemie AG have?
What happened to Wacker Chemie AG’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Wacker Chemie AG?
What is the TipRanks Smart Score and how is it calculated?
Wacker Chemie AG Stock Smart Score
Company Description
Wacker Chemie AG
Wacker Chemie AG is a global enterprise delivering a diverse portfolio of chemical products through its worldwide operations. The company's business is structured across four principal divisions: Wacker Silicones, Wacker Polymers, Wacker Biosolutions, and Wacker Polysilicon. The Wacker Silicones segment produces an extensive array of silicone-based items, including silanes, siloxanes, fluids, emulsions, elastomers, resins, and pyrogenic silicas, which are essential for industries such as construction, electronics, automotive, healthcare, and renewable energy. Meanwhile, Wacker Polymers specializes in the provision of binders and polymeric additives, notably dispersible polymer powders and vinyl acetate-ethylene dispersions, crucial for applications in construction, paper manufacturing, adhesives, paints, coatings, and fundamental chemical processes. Wacker Biosolutions focuses on bespoke biotechnological solutions and a specialized catalog of fine chemicals. Its offerings, encompassing pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl acetate solid resins, and acetylacetone, serve as key components for pharmaceutical active ingredients, food additives, and agricultural chemicals. Finally, the Wacker Polysilicon unit is dedicated to manufacturing hyperpure polysilicon, an indispensable material for both the semiconductor and solar energy sectors. Tracing its origins back to 1914, Wacker Chemie AG maintains its headquarters in Munich, Germany, and functions as a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.
- Sector
- Basicmaterials
- Industry
- Chemicals - Specialty
- CEO
- Christian Hartel
- Employees
- 16,084
- Website
- www.wacker.com
- Address
- Gisela-Stein-Strasse 1, Munich, BV, 81671, DE
Wacker Chemie AG (0NR4) Earnings & Revenues
0NR4 Company Deck
0NR4 Earnings Call
Earnings Call SentimentPositive
The call was broadly positive, supported by 9% sales growth, a 63% increase in underlying EBITDA, strong PACE savings, improved performance in Silicones and Polymers, solid liquidity, lower net debt, and reaffirmed full-year guidance with an expectation for the upper half of the range. However, management also highlighted subdued end-market demand, weak solar polysilicon conditions, underutilization, unresolved U.S. trade policy, and several nonrecurring or unsustainable earnings benefits. The positive operational and financial progress outweighed the stated challenges.
View all GB:0NR4 earnings summaries0NR4 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 5 | 10 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 4 | 0 | 8 |
